price
AN
NASDAQ · ANAB
AnaptysBio, Inc.
Healthcare · Biotechnology
$51.00
Down-$0.70 (-1.35%)
Updated Sep 27, 2026, 6:36 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.52B
- P/E ratio
- -18.91
- Dividend yield
- 0.00%
- 52-week range
- $20.79 – $73.30
- Volume
- 437.68K
- Avg. volume
- 462.18K
Price performance
ANAB price history
1M range · 19 trading sessions · Daily adjusted prices
ANAB closed at $51.00 after 19 trading sessions, down 10.57% for the selected period.
- Last close
- $51.00
- Period change
- -10.57%
- Period low
- $50.77
- Period high
- $57.46
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $52.38 | $52.38 | $50.7975 | $51.00 | 437.68K |
| Sep 24, 2026 | $50.59 | $52.16 | $50.35 | $51.70 | 418.4K |
| Sep 23, 2026 | $53.55 | $53.9275 | $49.4501 | $50.77 | 779.61K |
| Sep 22, 2026 | $55.07 | $56.04 | $50.61 | $53.92 | 755.77K |
| Sep 21, 2026 | $56.00 | $56.00 | $54.09 | $54.92 | 525.05K |
| Sep 18, 2026 | $55.76 | $55.77 | $53.71 | $55.20 | 868.85K |
| Sep 17, 2026 | $55.09 | $55.79 | $54.49 | $55.06 | 439.57K |
| Sep 16, 2026 | $54.44 | $54.80 | $53.6228 | $54.31 | 394.07K |
| Sep 15, 2026 | $54.28 | $55.32 | $53.22 | $54.68 | 351.77K |
| Sep 14, 2026 | $54.58 | $55.70 | $54.00 | $54.11 | 436.88K |
| Sep 11, 2026 | $55.43 | $56.315 | $53.75 | $53.87 | 336.19K |
| Sep 10, 2026 | $55.43 | $56.43 | $54.31 | $55.16 | 300.15K |
| Sep 9, 2026 | $55.59 | $57.89 | $55.25 | $55.70 | 295.68K |
| Sep 8, 2026 | $55.48 | $58.165 | $54.79 | $56.60 | 1.04M |
| Sep 4, 2026 | $56.84 | $58.77 | $56.10 | $56.80 | 1.06M |
| Sep 3, 2026 | $56.33 | $57.77 | $55.00 | $57.46 | 366.85K |
| Sep 2, 2026 | $56.13 | $57.90 | $54.66 | $55.84 | 421.73K |
| Sep 1, 2026 | $56.82 | $58.09 | $54.84 | $55.28 | 773.86K |
| Aug 31, 2026 | $55.83 | $57.22 | $55.00 | $57.03 | 332.17K |
Latest ANAB news
The latest Smart Investors Daily articles mentioning ANAB.
Stock researchResearch & News · Competitors
Loading stock research…